Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

NCT00631462

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

NCT00042016

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
  • Metro-Minnesota CCOP Saint Louis Park, Minnesota, United States
View Trial Details
Completed

Bone Marrow Transplant Chart Review for RIC

NCT00723333

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Baylor College of Medicine Houston, Texas, United States
  • M.D. Anderson Cancer Centers Houston, Texas, United States
  • University of Utah Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

NCT00352677

Conditions
Acute Lymphocytic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Charite University of Medicine Berlin, Germany
  • Johann Wolfgang Goethe Universität Frankfurt am Main, Germany
View Trial Details
Completed

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

NCT00064584

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions